KRT18 and Hepatic fibrosis: Moreover, the effects of AAA-1s on plasmatic and hepatic CK-18 levels indicated that these antibodies could also potentially influence liver fibrosis, as elevated CK-18 fragment levels have been strongly associated with the development of liver fibrosis in the context of MASLD and hepatitis C (HCV) [39].